These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 19175671)
1. A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide. Walsh DM; Thulin E; Minogue AM; Gustavsson N; Pang E; Teplow DB; Linse S FEBS J; 2009 Mar; 276(5):1266-81. PubMed ID: 19175671 [TBL] [Abstract][Full Text] [Related]
2. Expression and purification of 15N- and 13C-isotope labeled 40-residue human Alzheimer's β-amyloid peptide for NMR-based structural analysis. Long F; Cho W; Ishii Y Protein Expr Purif; 2011 Sep; 79(1):16-24. PubMed ID: 21640828 [TBL] [Abstract][Full Text] [Related]
3. Expression and purification of amyloid-beta peptides from Escherichia coli. Garai K; Crick SL; Mustafi SM; Frieden C Protein Expr Purif; 2009 Jul; 66(1):107-12. PubMed ID: 19233290 [TBL] [Abstract][Full Text] [Related]
4. Identification of peptides that specifically bind Abeta1-40 amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display. Kang CK; Jayasinha V; Martin PT Neurobiol Dis; 2003 Oct; 14(1):146-56. PubMed ID: 13678675 [TBL] [Abstract][Full Text] [Related]
5. An Efficient Method for the Expression and Purification of Aβ(M1-42). Yoo S; Zhang S; Kreutzer AG; Nowick JS Biochemistry; 2018 Jul; 57(26):3861-3866. PubMed ID: 29757632 [TBL] [Abstract][Full Text] [Related]
6. An Efficient Method of Expression and Purification of Amyloid-Beta (Aβ Ghosh D; Wälti MA; Riek R Methods Mol Biol; 2023; 2551():41-51. PubMed ID: 36310195 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of a highly soluble Aβ LeVatte MA; Lipfert M; Ladner-Keay C; Wishart DS Protein Expr Purif; 2019 Dec; 164():105480. PubMed ID: 31425755 [TBL] [Abstract][Full Text] [Related]
8. Direct evidence for self-propagation of different amyloid-β fibril conformations. Spirig T; Ovchinnikova O; Vagt T; Glockshuber R Neurodegener Dis; 2014; 14(3):151-9. PubMed ID: 25300967 [TBL] [Abstract][Full Text] [Related]
9. An expeditious and facile method of amyloid beta (1-42) purification. Haque MA; Park IS PLoS One; 2024; 19(7):e0307213. PubMed ID: 38990960 [TBL] [Abstract][Full Text] [Related]
12. An improved method for high-level soluble expression and purification of recombinant amyloid-beta peptide for in vitro studies. Chhetri G; Pandey T; Chinta R; Kumar A; Tripathi T Protein Expr Purif; 2015 Oct; 114():71-6. PubMed ID: 26118700 [TBL] [Abstract][Full Text] [Related]
13. Combining intracellular selection with protein-fragment complementation to derive Aβ interacting peptides. Acerra N; Kad NM; Mason JM Protein Eng Des Sel; 2013 Jul; 26(7):463-70. PubMed ID: 23708321 [TBL] [Abstract][Full Text] [Related]
14. N-terminal domain of myelin basic protein inhibits amyloid beta-protein fibril assembly. Liao MC; Hoos MD; Aucoin D; Ahmed M; Davis J; Smith SO; Van Nostrand WE J Biol Chem; 2010 Nov; 285(46):35590-8. PubMed ID: 20807757 [TBL] [Abstract][Full Text] [Related]
15. The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42. Finder VH; Vodopivec I; Nitsch RM; Glockshuber R J Mol Biol; 2010 Feb; 396(1):9-18. PubMed ID: 20026079 [TBL] [Abstract][Full Text] [Related]
16. Abeta produced as a fusion to maltose binding protein can be readily purified and stably associates with copper and zinc. Caine J; Volitakis I; Cherny R; Varghese J; Macreadie I Protein Pept Lett; 2007; 14(1):83-6. PubMed ID: 17266654 [TBL] [Abstract][Full Text] [Related]
18. Identification of the molecular interaction site of amyloid beta peptide by using a fluorescence assay. Watanabe K; Segawa T; Nakamura K; Kodaka M; Konakahara T; Okuno H J Pept Res; 2001 Oct; 58(4):342-6. PubMed ID: 11606220 [TBL] [Abstract][Full Text] [Related]
19. Photoaffinity cross-linking of Alzheimer's disease amyloid fibrils reveals interstrand contact regions between assembled beta-amyloid peptide subunits. Egnaczyk GF; Greis KD; Stimson ER; Maggio JE Biochemistry; 2001 Oct; 40(39):11706-14. PubMed ID: 11570871 [TBL] [Abstract][Full Text] [Related]
20. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system. Tackenberg C; Kulic L; Nitsch RM PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]